Literature DB >> 22748271

Clinical trial design in head and neck cancer: what has the oncologist learned?

David J Adelstein1.   

Abstract

Chemotherapy has assumed an important role in multidisciplinary management of patients with head and neck cancer. Much recent progress is attributable to successful design and careful implementation of clinical trials. In addition to showing the efficacy of chemotherapy, trials also instruct about how to improve experimental design so that we can make the most of what is learned. In this Personal View, several important studies in head and neck cancer are reviewed, with focus on issues raised by their design, potential solutions to these difficulties, and challenges that future investigations of this disease will face.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22748271     DOI: 10.1016/S1470-2045(12)70119-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  1 in total

1.  Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials.

Authors:  Mengmeng Wang; Huimin Tian; Gang Li; Tingwen Ge; Yudi Liu; Jiuwei Cui; Fujun Han
Journal:  Oncotarget       Date:  2016-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.